Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ACLC 2018
IASLC Asia Conference on Lung Cancer 2018
Access Abstracts and Powerpoint Slides to select presentations that took place during the IASLC Asia Conference on Lung Cancer 2018 in Guangzhou, China from November 8 - 10, 2018. This package is available for no charge to active IASLC Members.
Presentation Date(s):- November 8 - 10, 2018
- Total Presentations: 137
-
+
Poster Session
- Type: Poster Session
- Track:
- Presentations: 90
- Coordinates: 11/07/2018, 00:00 - 00:00, Poster Hall
-
+
P020 - Characterization of Met Exon 14 Skipping and Association with Clinical Outcomes of Crizotinib in Chinese Lung Cancers
00:00 - 00:00 | Author(s): H. Yang
- Abstract
Loading... -
+
P026 - Impact of Prior Cancer History on the Overall Survival of Younger Patients with Lung Cancer
00:00 - 00:00 | Author(s): H. Zhou
- Abstract
Loading... -
+
P038 - Docosapentaenoic Acid and Lung Cancer Risk: A Mendelian Randomisation Study
00:00 - 00:00 | Author(s): J. Liu
- Abstract
Loading... -
+
P053 - The Potential of Assessing Blood Tumor Mutation Burden (bTMB) Using a Large Panel
00:00 - 00:00 | Author(s): K. Zhang
- Abstract
Loading... -
+
P070 - Pembrolizumab for Non-Small Cell Lung Cancer with Untreated Central Nervous System Metastases: A Case Report
00:00 - 00:00 | Author(s): M. Di
- Abstract
Loading... -
+
P071 - Variants Distribution and Heterogeneity of Outcomes to Crizotinib in ALK-Rearranged Chinese Non-Small Cell Lung Cancers
00:00 - 00:00 | Author(s): N. Liang
- Abstract
Loading... -
+
P101 - Intratumor Heterogeneity Comparison Among Different Subtypes of
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P102 - The Correlations of Tumor Mutational Burden Among Single-region Tissue, Multi-region Tissues And Blood in NSCLC
00:00 - 00:00 | Author(s): Y. Zhang
- Abstract
Loading... -
+
P109 - Combined Chemotherapy Versus Topotecan Monotherapy as Second-Line Treatment for Patients with Sensitive Relapsed SCLC
00:00 - 00:00 | Author(s): L. Zhang
- Abstract
Loading...
-
+
Best abstracts selected from submissions 5
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 16:20 - 17:00, Crystal Ballroom 1
-
+
OA10 - CheckMate 078: Patient-Reported Outcomes (PROs) With Nivolumab vs Docetaxel in Advanced Non-Small Cell Lung Cancer (NSCLC)
06:30 - 06:40 | Author(s): Y. Wu
- Abstract
Loading...
-
+
Best abstracts selected from submissions 7
- Type: Oral Session
- Track:
- Presentations: 2
- Slides Available
- Coordinates: 11/09/2018, 16:20 - 17:00, Jade Ballroom
-
+
OA13 - High-dose Icotinib in Advanced NSCLC with EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study (Slides Available)
22:20 - 22:30 | Author(s): X. Li
- Abstract
Loading...
